Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 6;14(3):4126.
doi: 10.1120/jacmp.v14i3.4126.

Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy

Affiliations

Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy

Brendan M Prendergast et al. J Appl Clin Med Phys. .

Abstract

Stereotactic body radiation therapy (SBRT) employs precision target tracking and image-guidance techniques to deliver ablative doses of radiation to localized malignancies; however, treatment with conventional photon beams requires lengthy treatment and immobilization times. The use of flattening filter-free (FFF) beams operating at higher dose rates can shorten beam-on time, and we hypothesize that it will shorten overall treatment delivery time. A total of 111 lung and liver SBRT cases treated at our institution from July 2008 to July 2011 were reviewed and 99 cases with complete data were identified. Treatment delivery times for cases treated with a FFF linac versus a conventional dose rate linac were compared. The frequency and type of intrafraction image guidance was also collected and compared between groups. Three hundred and ninety-one individual SBRT fractions from 99 treatment plans were examined; 36 plans were treated with a FFF linac. In the FFF cohort, the mean (± standard deviation) treatment time (time elapsed from beam-on until treatment end) and patient's immobilization time (time from first alignment image until treatment end) was 11.44 (± 6.3) and 21.08 (± 6.8) minutes compared to 32.94 (± 14.8) and 47.05 (± 17.6) minutes for the conventional cohort (p < 0.01 for all values). Intrafraction-computed tomography (CT) was used more often in the conventional cohort (84% vs. 25%; p < 0.05), but use of orthogonal X-ray imaging remained the same (16% vs. 19%). For lung and liver SBRT, a FFF linac reduces treatment and immobilization time by more than 50% compared to a conventional linac. In addition, treatment with a FFF linac is associated with less physician-ordered image guidance, which contributes to further improvement in treatment delivery efficiency.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A schematic representation of the crossbeam profile of a conventional (with flattening filter) 10 megavolt photon beam (dashed line) is compared to the crossbeam profile of an unflattened photon beam (solid line) of equivalent energy. The unflattened beam has approximately four times higher dose rate at central axis.
Figure 2
Figure 2
Treatment delivery time comparison: the overall length of the bars indicates the total immobilization time (IT) was 46.8 minutes and 21.1 minutes for the conventional and FFF cohorts, respectively. The unshaded region represents image guidance time (IGT), which was only marginally different between the two groups (13.9 vs. 9.6 minutes for conventional and FFF, respectively). The checkered portion represents beam‐on time (BOT), which was more than two times longer in the conventional group than the FFF group (5.6 vs. 2.3 minutes, respectively). The striped region represents intrafraction downtime (IFDT), which was substantially longer for the conventional group than the FFF group (27.3 minutes vs. 9.2 minutes, respectively).

Similar articles

Cited by

References

    1. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi‐institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol. 2009;27(10):1579–84. - PubMed
    1. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi‐institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009;27(10):1572–78. - PubMed
    1. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non‐small cell lung cancer. J Thorac Oncol. 2007;2(7 Suppl 3):S101–S112. - PubMed
    1. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early‐stage lung cancer. J Clin Oncol. 2006;24(30):4833–39. - PubMed
    1. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63(5):1427–31. - PubMed